We are live on ! Find out more
TENX icon

Tenax Therapeutics
TENX

16 hedge funds and large institutions have $46.5M invested in Tenax Therapeutics in 2014 Q1 according to their latest regulatory filings, with 16 funds opening new positions, increasing their positions, reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

4,535% more capital invested

Capital invested by funds: $1M → $46.5M (+$45.5M)

220% more funds holding

Funds holding: 5 → 16 (+11)

220% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 5

57% more call options, than puts

Call options by funds: $368K | Put options by funds: $234K

Holders
16
Holders Change
+11
Holders Change %
+220%
% of All Funds
0.46%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.06%
New
16
Increased
–
Reduced
–
Closed
5
Calls
$368K
Puts
$234K
Net Calls
+$134K
Net Calls Change
+$134K

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$13.1M
2
GPP
Great Point Partners
Connecticut
+$12.5M
3
HM
HealthCor Management
New York
+$9.3M
4
BC
Broadfin Capital
New York
+$6.14M
5
DM
Deerfield Management
New York
+$3.37M

Top Sellers

Rank Fund Capital Flow
1
PAG
Private Advisor Group
New Jersey
-$493K
2
Barclays
Barclays
United Kingdom
-$198K
3
U
UBS
Switzerland
-$198K
4
EMG
Ellington Management Group
Connecticut
-$154K
5
TRCT
Tower Research Capital (TRC)
New York
-$79K
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$11.8M +$13.1M +66 New
GPP
2
Great Point Partners
Connecticut
$11.1M +$12.5M +63 New
HM
3
HealthCor Management
New York
$8.32M +$9.3M +47 New
BC
4
Broadfin Capital
New York
$5.51M +$6.14M +31 New
DM
5
Deerfield Management
New York
$3.05M +$3.37M +17 New
PRCM
6
Pine River Capital Management
Minnesota
$3M +$3.37M +17 New
Millennium Management
7
Millennium Management
New York
$956K +$990K +5 New
Bank of New York Mellon
8
Bank of New York Mellon
New York
$588K +$594K +3 New
Geode Capital Management
9
Geode Capital Management
Massachusetts
$427K +$396K +2 New
Susquehanna International Group
10
Susquehanna International Group
Pennsylvania
$306K +$396K +2 New
Vanguard Group
11
Vanguard Group
Pennsylvania
$279K +$396K +2 New
Verition Fund Management
12
Verition Fund Management
Connecticut
$278K +$396K +2 New
Morgan Stanley
13
Morgan Stanley
New York
$234K +$198K +1 New
BL
14
Bolton LP
Connecticut
$180K +$198K +1 New
Jane Street
15
Jane Street
New York
$139K +$198K +1 New
Nomura Holdings
16
Nomura Holdings
Japan
$128K +$198K +1 New
CS
17
Credit Suisse
Switzerland
$69K – – –
U
18
UBS
Switzerland
$68K -$198K -1 Closed
Northern Trust
19
Northern Trust
Illinois
$64K – – –
AIG
20
American International Group
New York
$38.9K – – –
Citigroup
21
Citigroup
New York
$10K – – –
Group One Trading
22
Group One Trading
Illinois
$8K – – –
Royal Bank of Canada
23
Royal Bank of Canada
Ontario, Canada
$4K – – –
TDC
24
Thompson Davis & Co
Virginia
$3K – – –
Wells Fargo
25
Wells Fargo
California
$3K – – –
1
2

TENX Hedge Fund Activity: Q1 2014 in Review

16 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q1 2014, worth a combined $46.5M — up 4,535% from $1M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new TENX positions and 5 closed out — a net gain of 11 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $13.1M. The largest seller was Private Advisor Group, exiting entirely with an estimated $493K sold.

  • 16 institutional investors held Tenax Therapeutics (TENX) as of Q1 2014, up from 5 in Q4 2013.
  • Funds reported $46.5M of Tenax Therapeutics stock for Q1 2014, up 4,535% quarter-over-quarter.
  • 16 funds opened new Tenax Therapeutics positions in Q1 2014 and 5 closed out, a net change of +11 holders.
  • The largest Tenax Therapeutics buyer in Q1 2014 was Sabby Management, an estimated $13.1M added.
  • The largest Tenax Therapeutics seller in Q1 2014 was Private Advisor Group, an estimated $493K sold.

Based on aggregated 13F filings for Q1 2014.